{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:28Z","timestamp":1791849388706,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09316-6","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T02:50:37Z","timestamp":1786157437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The neurologist of 2050: Rethinking the role in movement disorders in a technologically transformed society"],"prefix":"10.1007","volume":"47","author":[{"given":"Silvia","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-3772","authenticated-orcid":false,"given":"Carlo Alberto","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"9316_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1212\/WNL.0000000000200236","volume":"99","author":"A Mirelman","year":"2022","unstructured":"Mirelman A, Siderowf A, Chahine L (2022) Outcome assessment in Parkinson disease prevention trials: utility of clinical and digital measures. Neurology 99:52\u201360. https:\/\/doi.org\/10.1212\/WNL.0000000000200236","journal-title":"Neurology"},{"key":"9316_CR2","doi-asserted-by":"publisher","first-page":"077","DOI":"10.1055\/a-2596-5950","volume":"46","author":"A Deik","year":"2026","unstructured":"Deik A (2026) The Role of AI in the Management of Movement Disorders. Semin Neurol 46:077\u2013085. https:\/\/doi.org\/10.1055\/a-2596-5950","journal-title":"Semin Neurol"},{"key":"9316_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23:191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"key":"9316_CR4","doi-asserted-by":"publisher","unstructured":"Bougea A (2025) Mobile health technologies for the management of Parkinson\u2019s disease. 25(12):1425\u20131433. https:\/\/doi.org\/10.1080\/14737175.2025.2580468","DOI":"10.1080\/14737175.2025.2580468"},{"key":"9316_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.788427","volume":"13","author":"H Fr\u00f6hlich","year":"2022","unstructured":"Fr\u00f6hlich H, Bontridder N, Petrovska-Delacr\u00e9ta D et al (2022) Leveraging the potential of digital technology for better individualized treatment of Parkinson\u2019s disease. Front Neurol 13:788427. https:\/\/doi.org\/10.3389\/fneur.2022.788427","journal-title":"Front Neurol"},{"key":"9316_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41746-024-01144-2","volume":"7","author":"JM Janssen Daalen","year":"2024","unstructured":"Janssen Daalen JM, Van Den Bergh R, Prins EM et al (2024) Digital biomarkers for non-motor symptoms in Parkinson\u2019s disease: the state of the art. npj Digit Med 7:186. https:\/\/doi.org\/10.1038\/s41746-024-01144-2","journal-title":"npj Digit Med"},{"key":"9316_CR7","doi-asserted-by":"publisher","first-page":"102013","DOI":"10.1016\/j.arr.2023.102013","volume":"90","author":"R Gupta","year":"2023","unstructured":"Gupta R, Kumari S, Senapati A et al (2023) New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson\u2019s disease. Ageing Res Rev 90:102013. https:\/\/doi.org\/10.1016\/j.arr.2023.102013","journal-title":"Ageing Res Rev"},{"key":"9316_CR8","doi-asserted-by":"publisher","first-page":"111667","DOI":"10.1016\/j.brainresbull.2025.111667","volume":"234","author":"O Zarei","year":"2026","unstructured":"Zarei O, Talebi Moghaddam M, Moradi Vastegani S (2026) Machine learning and deep learning in clinical practice: Advancing neurodegenerative disease diagnosis with multimodal markers. Brain Res Bull 234:111667. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111667","journal-title":"Brain Res Bull"},{"key":"9316_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jamaneurol.2025.2781","volume":"82","author":"HM Bronte-Stewart","year":"2025","unstructured":"Bronte-Stewart HM, Beudel M, Ostrem JL et al (2025) Long-Term Personalized Adaptive Deep Brain Stimulation in Parkinson Disease: A Nonrandomized Clinical Trial. JAMA Neurol 82:1171\u20131180. https:\/\/doi.org\/10.1001\/jamaneurol.2025.2781","journal-title":"JAMA Neurol"},{"key":"9316_CR10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/14737175.2021.2000392","volume":"21","author":"L Di Biase","year":"2021","unstructured":"Di Biase L, Tinkhauser G, Martin Moraud E et al (2021) Adaptive, personalized closed-loop therapy for Parkinson\u2019s disease: biochemical, neurophysiological, and wearable sensing systems. Expert Rev Neurother 21:1371\u20131388. https:\/\/doi.org\/10.1080\/14737175.2021.2000392","journal-title":"Expert Rev Neurother"},{"key":"9316_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"9316_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jval.2026.01.014","volume":"29","author":"CA Godoy Junior","year":"2026","unstructured":"Godoy Junior CA, Boverhof BJ, Rutten-van M\u00f6lken MPMH et al (2026) Technological Maturity and Cost-Effectiveness of Medical Artificial Intelligence: A Systematic Review of Health Economic Evaluations. Value Health 29:896\u2013904. https:\/\/doi.org\/10.1016\/j.jval.2026.01.014","journal-title":"Value Health"},{"key":"9316_CR13","doi-asserted-by":"publisher","first-page":"e214356","DOI":"10.1212\/WNL.0000000000214356","volume":"105","author":"JA Budhu","year":"2025","unstructured":"Budhu JA, Anderson N, Branson C et al (2025) Health Equity Considerations in the Age of Artificial Intelligence. Neurology 105:e214356. https:\/\/doi.org\/10.1212\/WNL.0000000000214356","journal-title":"Neurology"},{"key":"9316_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/bioe.13158","volume":"37","author":"G Lorenzini","year":"2023","unstructured":"Lorenzini G, Arbelaez Ossa L, Shaw DM, Elger BS (2023) Artificial intelligence and the doctor\u2013patient relationship expanding the paradigm of shared decision making. Bioethics 37:424\u2013429. https:\/\/doi.org\/10.1111\/bioe.13158","journal-title":"Bioethics"},{"key":"9316_CR15","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202411","author":"A Shalash","year":"2021","unstructured":"Shalash A, Spindler M, Cubo E (2021) Global perspective on telemedicine for Parkinson\u2019s disease. J Parkinsons Dis. https:\/\/doi.org\/10.3233\/JPD-202411","journal-title":"J Parkinsons Dis"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09316-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:33:12Z","timestamp":1791847992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09316-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09316-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As a perspective study, the manuscript does not include data from patients or animals; therefore, no ethical committee approval or informed consent is required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG: no competing interests; CAA: no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"693"}}